Thursday, December 08, 2022 11:41:36 AM
My God fundamentals are rock solid news any moment support massive huge buys pouring in oh my
Recent COSM News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2026 08:30:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 01:30:32 PM
- Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants • ACCESS Newswire • 05/21/2026 06:20:00 PM
- Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway • ACCESS Newswire • 05/21/2026 01:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2026 08:31:01 PM
- Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Prog • ACCESS Newswire • 05/14/2026 01:00:00 PM
- Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 • ACCESS Newswire • 05/12/2026 02:15:00 PM
- Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months • ACCESS Newswire • 05/11/2026 06:25:00 PM
- Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness • ACCESS Newswire • 05/06/2026 02:35:00 PM
- Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months • ACCESS Newswire • 04/30/2026 04:50:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/25/2026 12:33:19 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:30:45 PM
- Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products • ACCESS Newswire • 04/21/2026 04:50:00 PM
- Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio • ACCESS Newswire • 04/20/2026 02:55:00 PM
- Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health • ACCESS Newswire • 04/17/2026 06:00:00 PM
- Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% • ACCESS Newswire • 04/16/2026 07:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 03:15:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 08:34:41 PM
- Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 20 • ACCESS Newswire • 04/15/2026 01:25:00 PM
- Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units • ACCESS Newswire • 04/13/2026 04:50:00 PM
- Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months • ACCESS Newswire • 04/10/2026 01:40:00 PM
- Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction • ACCESS Newswire • 04/08/2026 03:10:00 PM
- Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets • ACCESS Newswire • 04/01/2026 03:42:00 PM
